🧬 Rising Oncology Drug Costs Are Hurting Your Bottom Line — Here's How to Fight Back


Oncology practices face an uphill battle: cutting-edge cancer treatments come with soaring drug costs, delayed reimbursements, and ever-changing billing regulations. The result? Strained cash flow, tighter margins, and a constant balancing act between patient care and financial health.

In our latest blog, we dive into real-world, actionable strategies that can help you:
✅ Reduce drug acquisition costs through smarter inventory and pricing
✅ Leverage biosimilars, GPOs, and assistance programs to cut expenses
✅ Maximize reimbursement with accurate coding and RCM expertise
✅ Explore revenue-boosting options like the 340B program and value-based care models

💰 Whether you're managing a large oncology group or a solo practice, these strategies are built to protect your revenue—without compromising patient outcomes.

📖 [Read the full blog] and discover how Confair helps oncologists improve financial performance while focusing on what matters most: saving lives.

Comments

Post a Comment

Popular posts from this blog

🌐 Outsourcing Your Medical Billing? Don’t Make the Wrong Call.

Image
With healthcare costs on the rise, outsourcing your RCM operations can be a game-changer—but only if you choose the right offshore partner . A good choice boosts efficiency and accelerates collections. A poor one? It leads to compliance risks, claim denials, and revenue loss. 💥 Before you sign a contract, make sure your offshore billing partner checks these boxes: ✅ Deep knowledge of US medical billing & payer guidelines ✅ Strict HIPAA compliance and secure data handling ✅ Real-time visibility into workflows and KPIs ✅ Seamless communication across time zones ✅ Specialty-focused training and billing accuracy 📉 Don’t gamble on your revenue cycle. In our latest blog, we break down the Top 10 expert tips for choosing the right offshore medical billing company— the smart way . 💡 Plus: Why a 15-day trial is the safest way to test fit before committing long-term. 📖 [Read the full blog now] — and find out how Confair helps US billing companies scale with confidence .
Read more

💊 Think Clinical Judgment Is Enough for Drug Delivery Decisions? Think Again.

Image
In oncology, selecting the right therapy is only half the battle. The other half? Navigating complex drug policies that dictate how and if you’ll get reimbursed. 📉 Even FDA-approved treatments can be denied if they fall outside Medicare’s Local or National Coverage Determinations (LCDs/NCDs) . ⚠️ Medicaid policies vary drastically by state — one wrong step can lead to claim denials and compliance risks . 🚫 And don’t forget commercial payers with strict carve-out rules that can block buy-and-bill entirely. If your practice isn’t aligned with these policies, you're not just risking revenue—you’re risking delays in patient care . 🧠 In our latest blog, we break down: Why LCD/NCD awareness must be part of your workflow How state Medicaid rules can impact infused drug billing What commercial pharmacy mandates mean for your procurement model And how policy non-compliance could trigger audits or non-payment ✅ Learn how top-performing oncology practices use po...
Read more

Why More Medical Billing Companies Are Going Offshore in 2025

Image
In 2025, a major shift is happening in the U.S. medical billing industry—and it’s all about offshore outsourcing. With rising costs, talent shortages, and the push for efficiency, many billing companies are exploring offshore RCM partnerships to stay competitive. But is it just about cost savings? Or is there more to the story? 👉 Discover why the offshore model is becoming the preferred choice for U.S. billing companies—and how it’s changing the future of healthcare revenue management. 🔗 Read the full article on our official blog: Why US Medical Billing Companies Are Choosing Offshore Medical Billing in 2025
Read more